NCT05370391 Comprehensive Behavioral Intervention for Tics
| NCT ID | NCT05370391 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Tic Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-09-09 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-09-09 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.
Eligibility Criteria
Inclusion criteria * A current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Tic disorder (e.g., Tourette's Disorder/syndrome, Persistent (Chronic) Motor or Vocal Tic Disorder, or Provisional Tic Disorder) or caregiver/youth report of clinically impairing tic symptoms * Ability for youth to speak/read English sufficiently * At least one parent/caregiver available to sign study consent forms, remain present during assessments, and fill out study questionnaires in English. Exclusion criteria * A current diagnosis of psychosis, bipolar disorder, intellectual disability, acute suicidality, alcohol/substance dependence, or eating disorder. * Youth currently receiving psychotherapy elsewhere and/or have previously received CBIT. * Currently suicidal or who have engaged in suicidal behaviors within the past 6 months will be excluded * Youth currently taking psychotropic medication for a co-morbid psychiatric illness will be included without a wash-out period (to not delay treatment).
Contact & Investigator
Jill Ehrenreich-May, Ph.D.
STUDY DIRECTOR
University of Miami
Frequently Asked Questions
Who can join the NCT05370391 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 17 Years, studying Tic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05370391 currently recruiting?
Yes, NCT05370391 is actively recruiting participants. Contact the research team at d.ibarra@umiami.edu for enrollment information.
Where is the NCT05370391 trial being conducted?
This trial is being conducted at Coral Gables, United States.
Who is sponsoring the NCT05370391 clinical trial?
NCT05370391 is sponsored by University of Miami. The principal investigator is Jill Ehrenreich-May, Ph.D. at University of Miami. The trial plans to enroll 200 participants.